Etid klinik pou BPCO nan Pennsylvania
33 etid pou BPCO ap chèche patisipan nan sit nan Pennsylvania.
Vil nan Pennsylvania
Tèks ofisyèl etid la (Anglè)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Suburban Research Associates - Media- Site Number : 8400143, Media
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Oct 1, 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research Associates of Central PA, LLC, DuBois
- DM Clinical Research - Philadelphia, Philadelphia
Ap rekriteFaz 2
Laj 40 a 85 · Tout sèks · Mizajou Sep 30, 2026 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Clinical Research Associates of Central PA, DuBois
Ap rekriteFaz 2
Laj 40 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07759245A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50002, DuBois
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 25, 2026 · NCT07725939A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Clinical Research Associates of Central Pennsylvania- Site Number : 8400002, DuBois
Ap rekriteFaz 4
Laj 40 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Temple University Hospital- Site Number : 8400059, Philadelphia
- Preferred Primary Care Physicians - Pleasant Hills- Site Number : 8400092, Pittsburgh
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Penn Medicine, Philadelphia
- Temple University, Philadelphia
- Allegheny General Hospital, Pittsburgh
- ak 1 plis
Ap rekrite
Laj 40 a 80 · Tout sèks · Mizajou Sep 17, 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, DuBois
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Camp Hill
- Research Site, DuBois
- Research Site, Philadelphia
- ak 4 plis
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Temple University, Philadelphia
- University of Pittsburgh, Pittsburgh
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Horsham
- Research Site, Pittsburgh
- Research Site, Sayre
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, DuBois
- Research Site, Philadelphia
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- UPMC Montefiore Hospital, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06603246COPD Exacerbation Follow Up
- Thomas Jefferson University, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 40 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07118306A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Clinical Research Associates of Central PA, LLC, DuBois
Ap rekriteFaz 2/3
Laj 35 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Camp Hill
- Research Site, Philadelphia
- Research Site, Philadelphia
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Aug 26, 2026 · NCT06283966STRIVE Post-Market Registry Study
- Penn State Milton S. Hershey Medical Center, Hershey
- Temple University, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- Reading Hospital, West Reading
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, DuBois
- GSK Investigational Site, West Chester
Ap rekriteFaz 3
Laj 40 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07177339Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- Temple University Hospital, Philadelphia
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- Temple University, Philadelphia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 a 55 · Tout sèks · Mizajou Jun 3, 2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Penn Highlands - Lung Innovations/Clinical Research Associates, DuBois
- Temple University - Temple Lung Center, Philadelphia
- University of Pittsburgh Medical Center - UMPC Comprehensive Lung Center, Pittsburgh
Ap rekrite
Laj 40 a 80 · Tout sèks · Mizajou Apr 28, 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Clinical Research Associates of Central Pennsylvania, DuBois
- Temple University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
Ap rekrite
Laj 40 a 84 · Tout sèks · Mizajou Apr 24, 2026 · NCT06891755Feasibility of Semaglutide in Advanced Lung Disease
- University of Pennsylvania Perelman School of Medicine, Philadelphia
Ap rekriteFaz 1/2
Laj 18 a 80 · Tout sèks · Mizajou Apr 21, 2026 · NCT05746039Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Apr 9, 2026 · NCT06961214Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
- Thomas Jefferson University, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 50 a 80 · Tout sèks · Mizajou Mar 3, 2026 · NCT06974981Supporting Evidence-based Responses to Emotional Needs in Emphysema
- University of Pennsylvania, Philadelphia
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT06600126Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
- UPMC Presbyterian, Pittsburgh
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Ap rekriteFaz 1/2
Laj 18 a 60 · Tout sèks · Mizajou Jan 13, 2026 · NCT03500731Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
Ap rekriteVolontè an sante akeyi
Laj 8 a 70 · Tout sèks · Mizajou Oct 24, 2025 · NCT06512064Emphysema Research Registry and Biosample Repository
- University of Pittsburgh Emphysema/COPD Research Center, Pittsburgh
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 ak plis · Tout sèks · Mizajou Sep 25, 2025 · NCT00307281Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Clinical Research Associates of Central PA, DuBois
- US Digestive Health at Lancaster, Lancaster
- Temple University, Philadelphia
- ak 2 plis
Ap rekriteEtid obsèvasyon
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2025 · NCT06122077Temple Health Chest Initiative (THCI 2.0)
- Temple University Of the Commonwealth System of Higher Education, Philadelphia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 50 a 80 · Tout sèks · Mizajou Apr 18, 2025 · NCT06933758myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- St. Luke's University Health Network, Bethlehem
- Clinical Research Associates of Central Pennsylvania, DuBois
- Jeanes Hospital, Philadelphia
- ak 2 plis
Ap rekrite
Laj 30 ak plis · Tout sèks · Mizajou Feb 6, 2025 · NCT05204888Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.